PMID- 31138945
OWN - NLM
STAT- MEDLINE
DCOM- 20191211
LR  - 20220408
IS  - 2616-163X (Electronic)
IS  - 0016-9560 (Print)
IS  - 0016-9560 (Linking)
VI  - 53
IP  - 1
DP  - 2019 Mar
TI  - Ghana's HIV epidemic and PEPFAR's contribution towards epidemic control.
PG  - 59-62
LID - 10.4314/gmj.v53i1.9 [doi]
AB  - BACKGROUND: The aim of this review was to summarize the data on HIV/AIDS 
      epidemiology and affected populations in Ghana and to describe the United States 
      President's Emergency Plan for Emergency Relief's (PEPFAR) response to the 
      epidemic. DESIGN: We conducted a literature review focusing on PEPFAR's 
      contribution to the HIV response in Ghana. Additionally, we summarized the 
      epidemiology of HIV. We searched both peer-reviewed and grey literature. SETTING: 
      Ghana. RESULTS: Overall, HIV prevalence in Ghana is 1.6% with regional variation. 
      Key populations (KPs) are disproportionately affected by HIV in the country. FSW 
      and their clients, and MSM, account for 28% of all new infections. PEPFAR 
      provides technical assistance (TA) to Ghana to maximize the quality, coverage and 
      impact of the national HIV/AIDS response. To ensure adequate supply of 
      antiretrovirals (ARVs), in 2016-2017, PEPFAR invested $23.7 million as a onetime 
      supplemental funding to support Ghana's ARV treatment program. In addition, the 
      National AIDS Control Programme in collaboration with PEPFAR is implementing a 
      scale up of viral load testing. PEPFAR is also implementing a comprehensive 
      package of prevention services in five regions to help reach MSM and FSW and to 
      expand HIV testing services for KPs. CONCLUSIONS: Ghana is making changes at both 
      policy and program level in the fight against HIV/AIDS and is working towards 
      achieving the UNAIDS' 90-90-90 targets. PEPFAR is providing TA to ensure these 
      goals can be achieved. FUNDING: This manuscript has been supported by the U.S. 
      President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for 
      Disease Control and Prevention (CDC).
FAU - Ali, Hammad
AU  - Ali H
AD  - Division of Global HIV and Tuberculosis, Centers for Disease Control and 
      Prevention, Atlanta, Georgia, USA.
FAU - Amoyaw, Frank
AU  - Amoyaw F
AD  - Division of Global HIV and Tuberculosis, Centers for Disease Control and 
      Prevention, Accra, Ghana.
FAU - Baden, Dan
AU  - Baden D
AD  - Division of Global HIV and Tuberculosis, Centers for Disease Control and 
      Prevention, Accra, Ghana.
FAU - Durand, Lizette
AU  - Durand L
AD  - Division of Global HIV and Tuberculosis, Centers for Disease Control and 
      Prevention, Atlanta, Georgia, USA.
FAU - Bronson, Megan
AU  - Bronson M
AD  - Division of Global HIV and Tuberculosis, Centers for Disease Control and 
      Prevention, Atlanta, Georgia, USA.
FAU - Kim, Andrea
AU  - Kim A
AD  - Division of Global HIV and Tuberculosis, Centers for Disease Control and 
      Prevention, Atlanta, Georgia, USA.
FAU - Grant-Greene, Yoran
AU  - Grant-Greene Y
AD  - Division of Global HIV and Tuberculosis, Centers for Disease Control and 
      Prevention, Atlanta, Georgia, USA.
FAU - Imtiaz, Rubina
AU  - Imtiaz R
AD  - Division of Global HIV and Tuberculosis, Centers for Disease Control and 
      Prevention, Atlanta, Georgia, USA.
FAU - Swaminathan, Mahesh
AU  - Swaminathan M
AD  - Division of Global HIV and Tuberculosis, Centers for Disease Control and 
      Prevention, Atlanta, Georgia, USA.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Ghana
TA  - Ghana Med J
JT  - Ghana medical journal
JID - 0073210
RN  - 0 (Anti-HIV Agents)
SB  - IM
MH  - Anti-HIV Agents/*economics/*supply & distribution/therapeutic use
MH  - Developing Countries
MH  - Ghana/epidemiology
MH  - HIV Infections/*drug therapy/*epidemiology
MH  - Homosexuality
MH  - Humans
MH  - *International Cooperation
MH  - Prevalence
MH  - Program Evaluation
MH  - Viral Load
PMC - PMC6527824
OTO - NOTNLM
OT  - Ghana
OT  - HIV
OT  - PEPFAR
OT  - epidemic
COIS- Conflict of interest: None declared
EDAT- 2019/05/30 06:00
MHDA- 2019/12/18 06:00
PMCR- 2019/03/01
CRDT- 2019/05/30 06:00
PHST- 2019/05/30 06:00 [entrez]
PHST- 2019/05/30 06:00 [pubmed]
PHST- 2019/12/18 06:00 [medline]
PHST- 2019/03/01 00:00 [pmc-release]
AID - jGMJ.v53.i1.pg59 [pii]
AID - 10.4314/gmj.v53i1.9 [doi]
PST - ppublish
SO  - Ghana Med J. 2019 Mar;53(1):59-62. doi: 10.4314/gmj.v53i1.9.